KCTD17-related myoclonus-dystonia syndrome: clinical and electrophysiological findings of a patient with atypical late onset.

[1]  E. Bertini,et al.  A novel KCTD17 mutation is associated with childhood early-onset hyperkinetic movement disorder. , 2019, Parkinsonism & related disorders.

[2]  B. Pérez-Dueñas,et al.  Childhood onset progressive myoclonic dystonia due to a de novo KCTD17 splicing mutation. , 2019, Parkinsonism & related disorders.

[3]  M. Vidailhet,et al.  Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment , 2018, Current opinion in neurology.

[4]  A. Bullock,et al.  Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases , 2017, The Biochemical journal.

[5]  M. Todisco,et al.  Specific patterns of laryngeal electromyography during wakefulness are associated to sleep disordered breathing and nocturnal stridor in multiple system atrophy. , 2016, Parkinsonism & related disorders.

[6]  P. Hedera,et al.  Speech-activated Myoclonus Mimicking Stuttering in a Patient with Myoclonus–Dystonia Syndrome , 2016, Tremor and other hyperkinetic movements.

[7]  Deborah Hughes,et al.  A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia. , 2015, American journal of human genetics.

[8]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[9]  J. Jankovic,et al.  Palatal myoclonus: An unusual presentation , 2005, Movement disorders : official journal of the Movement Disorder Society.

[10]  Hee Taek Kim,et al.  The epsilon-sarcoglycan gene in myoclonic syndromes , 2005, Neurology.

[11]  M. Hallett,et al.  Electrophysiological studies of myoclonus , 2000, Muscle & nerve.

[12]  M. Brin,et al.  Adductor spasmodic dysphonia: standard evaluation of symptoms and severity. , 1997, Journal of voice : official journal of the Voice Foundation.

[13]  W Poewe,et al.  Botulinum toxin in writer's cramp: objective response evaluation in 31 patients. , 1996, Journal of neurology, neurosurgery, and psychiatry.